Polysaccharides-based delivery systems and interpolyelectrolyte complexes (IPECs) are interesting alternatives to control the release of drugs, thereby improving therapies. Benznidazole (BZ) is the selected drug for Chagas disease pharmacotherapy. However, its side effects limit its efficacy and safety. We developed novel multiparticulated BZ-loaded IPECs based on chitosan and alginic acid, and investigated their physicochemical and pharmacotechnical properties. IPECs were obtained using the casting solvent method, followed by wet granulation. They presented ionic interaction between the biopolymers, revealed that free BZ was uniformly distributed and showed adequate flow properties for hard gelatin-capsule formulation. The multiparticles e...
This study was aimed to design a simple and novel prototype device for the production of polymeric m...
This article describes the characterization of various encapsulated formulations of benznidazole, th...
This article describes the characterization of various encapsulated formulations of benznidazole, th...
Interpolyelectrolyte complexes (IPEC) formulated as multiparticulate drug delivery systems (MDDS) ar...
Benznidazole (BZ), first-line drug for Chagas treatment, is available as immediate-release tablets. ...
Benznidazole (BZL), the first line drug for Chagas disease treatment, presents a low solubility, lim...
Chagas disease is a serious parasitic infection caused by Trypanosoma cruzi. Unfortunately, the curr...
This work aims to develop novel benznidazole (BZN) solid dispersions (SD) to improve its solubility ...
Benznidazole and nifurtimox are the only drugs specifically approved for the treatment of Chagas dis...
AbstractBenznidazole (BNZ) is the drug of choice for Chagas disease treatment, which affects about 9...
Benznidazole (BZ) is a first-line drug for the treatment of Chagas disease; however, it presents sev...
Solid dispersions (SD) of benznidazole (BNZ) in sodium deoxycholate (NaDC) or low-substituted hydrox...
Chagas' disease is caused by the protozoan parasite Trypanosoma cruzi. About 8. million people throu...
Chagas disease is caused by infection with the protozoan parasite Trypanosoma cruzi (T. cruzi), an i...
The use of chitosan functionalized silica for benznidazole delivery in the treatment of neglected di...
This study was aimed to design a simple and novel prototype device for the production of polymeric m...
This article describes the characterization of various encapsulated formulations of benznidazole, th...
This article describes the characterization of various encapsulated formulations of benznidazole, th...
Interpolyelectrolyte complexes (IPEC) formulated as multiparticulate drug delivery systems (MDDS) ar...
Benznidazole (BZ), first-line drug for Chagas treatment, is available as immediate-release tablets. ...
Benznidazole (BZL), the first line drug for Chagas disease treatment, presents a low solubility, lim...
Chagas disease is a serious parasitic infection caused by Trypanosoma cruzi. Unfortunately, the curr...
This work aims to develop novel benznidazole (BZN) solid dispersions (SD) to improve its solubility ...
Benznidazole and nifurtimox are the only drugs specifically approved for the treatment of Chagas dis...
AbstractBenznidazole (BNZ) is the drug of choice for Chagas disease treatment, which affects about 9...
Benznidazole (BZ) is a first-line drug for the treatment of Chagas disease; however, it presents sev...
Solid dispersions (SD) of benznidazole (BNZ) in sodium deoxycholate (NaDC) or low-substituted hydrox...
Chagas' disease is caused by the protozoan parasite Trypanosoma cruzi. About 8. million people throu...
Chagas disease is caused by infection with the protozoan parasite Trypanosoma cruzi (T. cruzi), an i...
The use of chitosan functionalized silica for benznidazole delivery in the treatment of neglected di...
This study was aimed to design a simple and novel prototype device for the production of polymeric m...
This article describes the characterization of various encapsulated formulations of benznidazole, th...
This article describes the characterization of various encapsulated formulations of benznidazole, th...